A member of the European and International Advocacy team since 2017, Simone contributes to European policy development and specifically represents EURORDIS in policy discussions on development access to therapies, with a focus on reducing delays and inequalities, on the underlying challenges in the field of the value assessment, pricing and reimbursement of orphan medicines, and on current initiatives towards improved access. He is engaged in finding new policy solutions for improving access to innovative therapies for people with rare diseases. 
 
Simone has over fifteen years of experience in the European public affairs arena, having previously worked for two leading consultancies in Brussels and specialised in health advocacy and government affairs in particular. He has in-depth expertise in healthcare beyond rare diseases having devised and implemented advocacy campaigns at the EU and national levels on a range of global health issues from sustainable health systems, chronic diseases, and healthy ageing to mental health, neurodegenerative diseases, malaria, TB and hepatitis C.